Covalon Technologies PE Ratio 2013-2024 | CVALF

Covalon Technologies PE ratio as of September 18, 2024 is 0.00.

Current and historical p/e ratio for Covalon Technologies (CVALF) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Covalon Technologies PE Ratio 2013-2024 | CVALF

Current and historical p/e ratio for Covalon Technologies (CVALF) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$234.6B
Intuitive Surgical (ISRG)$174.6B
Alcon (ALC)$48.6B
IQVIA Holdings (IQV)$43.6B
IDEXX Laboratories (IDXX)$42.1B
Edwards Lifesciences (EW)$41.8B
DexCom (DXCM)$28.1B
STERIS (STE)$24B
SONOVA HOLDING (SONVY)$21.5B
Waters (WAT)$19.5B
Hologic (HOLX)$19.2B
Sysmex ADR (SSMXY)$12.3B
Fresenius Medical Care AG KGaA (FMS)$12.3B
Teleflex (TFX)$11.6B
Globus Medical (GMED)$9.5B
Penumbra (PEN)$7.3B
Glaukos (GKOS)$6.8B
Masimo (MASI)$6.1B
TransMedics (TMDX)$5B
Integer Holdings (ITGR)$4.3B
PROCEPT BioRobotics (PRCT)$4.3B
Tandem Diabetes Care (TNDM)$2.8B
Inari Medical (NARI)$2.7B
LivaNova (LIVN)$2.6B
Nihon Kohden (NHNKY)$2.6B
Veracyte (VCYT)$2.6B
Elekta AB (EKTAY)$2.4B
RxSight (RXST)$2.1B
Integra LifeSciences Holdings (IART)$1.3B
Pulse Biosciences (PLSE)$1.2B